Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags US: News Eli Lilly and Co Eisai Co Ltd
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News FedEx Corp US STEEL DRN
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags AstraZeneca PLC Health care industry Pfizer Inc
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Health care industry Breaking news Companies
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags US: News Eli Lilly and Co Business
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Politics Markets World economy
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Novo Nordisk A/S Stock Picks stocks
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Abbott Laboratories Sanofi SA Pfizer Inc
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Health & Science Business Biotechnology
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Business News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Eli Lilly and Co Investing Stock markets
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Eli Lilly and Co US: News Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Home Depot Inc Economy Walmart Inc
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Business News Health care industry Pharmaceuticals
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Stock markets Target Corp Business
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags stocks Business News Aehr Test Systems
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Companies Social issues Breaking news
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Biotechnology Business Health & Science
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Business Biotechnology US: News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Biotech and Pharmaceuticals Pharmaceuticals Breaking News: Earnings
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags COVID/19 Business Biotechnology
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health & Science Apple Inc Enterprise
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Market Outlook Prices World Markets
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Consumer prices Markets Alphabet Inc
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Health care industry Investing Eli Lilly and Co
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Eli Lilly and Co US: News Walgreens Boots Alliance Inc
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Health care industry Weight management Weight loss diets
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Tags Biotechnology Business Earnings
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.